Lamivudine-Associated Lactic Acidosis

Affiliations

¹ Division of Medical Oncology, Department of Internal Medicine, Ashland Bellefonte Cancer Center, Ashland, KY.
² Division of Nephrology, The Nephrology Group, Fresno, CA.
³ Division of Nephrology, Renal Care Consultants, Medford, OR.
⁴ Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
⁵ Department of Rheumatology, Adventist Medical Center, Hanford, CA.
⁶ Department of Medicine, St. Agnes Medical Center, Fresno, CA.
⁷ Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.

Venu Madhav Konala et al. Am J Ther. 2022.

. 2022 Jul 1;29(4):449-451.

doi: 10.1097/MJT.0000000000000922.

¹ Division of Medical Oncology, Department of Internal Medicine, Ashland Bellefonte Cancer Center, Ashland, KY.
² Division of Nephrology, The Nephrology Group, Fresno, CA.
³ Division of Nephrology, Renal Care Consultants, Medford, OR.
⁴ Division of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
⁵ Department of Rheumatology, Adventist Medical Center, Hanford, CA.
⁶ Department of Medicine, St. Agnes Medical Center, Fresno, CA.
⁷ Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to declare.

1. Arenas-Pinto A, Grant AD, Edwards S, et al. Lactic acidosis in HIV infected patients: a systematic review of published cases. Sex Transm Infect. 2003;79:340–343.
1. Tripuraneni NS, Smith PR, Weedon J, et al. Prognostic factors in lactic acidosis syndrome caused by nucleoside reverse transcriptase inhibitors: report of eight cases and review of the literature. AIDS Patient Care STDS. 2004;18:379–384.
1. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2002;46:716–723.
1. Mokrzycki MH, Harris C, May H, et al. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis. 2000;30:198–200.
1. Miller KD, Cameron M, Wood LV, et al. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med. 2000;133:192–196.